封面
市場調查報告書
商品編碼
1640709

藥用塑膠瓶:市場佔有率分析、行業趨勢和成長預測(2025-2030 年)

Pharmaceutical Plastic Bottles - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: | 出版商: Mordor Intelligence | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2025 年醫藥塑膠瓶市場規模為 96 億美元,預計到 2030 年將達到 117.1 億美元,預測期內(2025-2030 年)的複合年成長率為 4.07%。

藥用塑膠瓶-市場-IMG1

預計在預測期內,用於儲存和分銷藥品的藥品包裝需求不斷成長將推動市場發展。

主要亮點

  • 由於塑膠包裝具有無與倫比的性能,製藥業對塑膠包裝的需求呈現顯著成長。此外,其阻隔性、高尺寸穩定性、高衝擊強度、抗變形、低吸水率、透明性、耐熱性、阻燃性、延長保存期限等特性也使其在醫藥領域的用途廣泛擴展。
  • 由於製藥業越來越重視永續性,提高回收率並盡量減少對環境的影響,製藥塑膠瓶市場正在不斷擴大。技術進步和塑膠瓶在固態甚至液體口服藥物中的使用日益增多,推動了藥用塑膠瓶市場的成長。然而,原油價格的波動和各種法規導致的塑膠價格上漲可能會影響產品的消費並進一步阻礙研究市場的成長。
  • 業界擴大使用塑膠瓶進行無菌填充和包裝。市場供應商在各地區提供無菌瓶灌裝包裝服務。例如,LSNE 提供無菌滴管瓶填充服務。本公司擁有自動化填充線,可填充5ml、10ml標準多劑量三件瓶以及無菌多劑量瓶。
  • 亞太地區是 PET 樹脂和聚合物的重要生產中心,不存在供不應求的問題,從而推動了市場成長。中國是最大的寶特瓶生產國和消費國之一。
  • 由於對藥品和其他必需品的需求從未如此高漲,用於包裝和運輸這些產品的包裝材料卻出現短缺,導致供應鏈嚴重中斷。然而,一些用於治療新冠肺炎患者的藥物的需求增加。這些藥物包括麻醉劑、抗生素、肌肉鬆弛劑和仿單標示外用藥。這導致向製藥公司供應塑膠瓶。

醫藥塑膠瓶市場趨勢

HDPE 細分市場成長率最高

  • HDPE 用於製造多種不同類型的瓶子,包括無色瓶子,這些瓶子是半透明的,並具有優異的剛性和阻隔性。該材料還帶有色素,可用於製藥業包裝光敏藥物。這些材料適合包裝保存期限較短的產品。根據美國工業理事會預測,2021年美國樹脂產量將達1,239億磅,其中熱塑性塑膠約佔總產量的86%。當年產量最大的樹脂是高密度聚苯乙烯(HDPE),產量為220億磅。
  • HDPE 還具有出色的耐化學性,用於包裝各種化學物質和藥品。事實證明,與不含顏料的 HDPE 材料相比,含顏料的 HDPE 瓶具有更好的抗應力開裂性。 HDPE吹塑成型應用比 PP 和 LDPE 材質更耐用且用途更廣泛。與其他聚乙烯材料相比,它還具有更好的耐大多數溶劑性和更高的抗張強度。
  • HDPE 還具有一些更常見聚合物的高強度重量比,並且比 PP 更脆,因此主要用於大型商業容器。高密度聚乙烯 (HDPE) 在成型時仍保持較輕的重量,使其成為塑膠罐等較大容器的理想選擇。
  • 此外,市場多個參與者正在進行各種研究和開發工作。例如,2021 年 4 月,Advil 製造商葛蘭素史克消費者保健公司 (GSK) 宣布承諾將其 8,000 多萬瓶 Advil 瓶中的塑膠減少 20%。到 2022 年,我們計劃從商店和網上銷售的幾乎所有瓶子中消除塑膠,Advil 品牌易開瓶除外。新型阻隔樹脂技術減少了模製和轉化高密度聚苯乙烯(HDPE) 瓶所需的樹脂量,同時保持了阻隔保護性能。

北美佔據主要市場佔有率

  • 由於塑膠容器和瓶子的消費量和工業用途不斷增加,美國塑膠瓶市場預計將呈現穩定的成長率。據美國塑膠工業委員會(PLASTICS)稱,美國塑膠瓶的市場需求持續成長。
  • 根據美國製藥商業協會報道,美國醫藥市場正呈現上升趨勢。到 2023 年,美國人預計在藥品上的支出將在 6,350 億美元至 6,550 億美元之間。因此,美國是藥品支出最多的國家。
  • 此外,據美國製藥商業協會稱,美國醫藥市場正在崛起。到 2023 年,美國人預計在藥品上的支出將在 6,350 億美元至 6,550 億美元之間。因此,它幾乎肯定會成為藥品支出最高的國家。
  • 塑膠樹脂及產品部門在 1,932 家機構僱用了 93,000 名員工。塑膠產品幾乎用於所有現代產品,加拿大經濟的大多數領域都需要塑膠產品,其中包裝、建築和汽車三大類佔塑膠最終用途的 69%。

藥用塑膠瓶產業概況

藥用塑膠瓶市場主要由 Amcor Limited、Berry Plastics Group, Inc.Berry Plastics Group, Inc.、Aptar Pharma、Gerresheimer AG、Graham Packaging Company、Alpha Packaging、Alpack Plastic Packaging 等公司主導。參與者正在採用各種有機和無機策略(如併購、夥伴關係、新產品發布、協作等)來佔領市場。

  • 2021 年 12 月-Comal 宣布已收購射出射出成型和吹塑成型產品製造商 Omega Packaging。 Omega Packaging 的兒童防護封蓋產品組合和精密模具製造能力推動了 Comal 的策略,即透過端到端客自訂製造能力和擴大的產品系列。
  • 2021 年 9 月 - Clearlake Capital Group 的投資組合公司 Pretium Packaging 同意從 Irving Place Capital 收購美國Alpha Packaging,收購金額未公開。 Alpha Packaging 和 Pretium Packaging 的合併將使兩家公司能夠為現有和新客戶提供更廣泛的先進包裝解決方案。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 研究假設和市場定義
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場洞察

  • 市場概況
  • 產業吸引力-波特五力分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭對手之間的競爭強度
  • 產業價值鏈分析
  • COVID-19 市場影響評估

第5章 市場動態

  • 市場促進因素
    • 消費者對輕型藥瓶的需求不斷增加
    • 醫療保健和藥品支出的增加將推動市場成長
  • 市場限制
    • 原料成本上漲
    • 對塑膠使用的環境擔憂

第6章 市場細分

  • 按原料
    • 聚對苯二甲酸乙二醇酯(PET)
    • 聚丙烯(PP)
    • 低密度聚乙烯(LDPE)
    • 高密度聚苯乙烯(HDPE)
  • 按類型
    • 固態容器
    • 滴管瓶
    • 滴鼻劑瓶
    • 液體瓶
    • 口腔護理
    • 其他類型
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
    • 亞洲
      • 中國
      • 印度
      • 日本
    • 澳洲和紐西蘭
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
    • 中東和非洲
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非

第7章 競爭格局

  • 公司簡介
    • Amcor Limited
    • Gerresheimer AG
    • Berry Group Inc.
    • Aptar Pharma
    • O.Berk Company LLC
    • Alpha Packaging
    • Pro-Pac Packaging Ltd
    • COMAR LLC
    • Gil Plastic Products Ltd
    • Drug Plastics Group
    • Frapak Packaging

第8章投資分析

第9章 市場機會與未來趨勢

簡介目錄
Product Code: 57357

The Pharmaceutical Plastic Bottles Market size is estimated at USD 9.60 billion in 2025, and is expected to reach USD 11.71 billion by 2030, at a CAGR of 4.07% during the forecast period (2025-2030).

Pharmaceutical Plastic Bottles - Market - IMG1

The growing demand for the packaging in pharmaceuticals for the storage and delivery of medicines is expected to drive the market during the forecast period.

Key Highlights

  • The demand for plastic packaging has witnessed significant growth in the pharmaceutical industry because of its unmatched ability. Additional features that led to increased adoption in pharma are barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.
  • The market for pharmaceutical plastic bottles is growing due to growing sustainability concerns by increasing the recycling rate and minimizing the environmental impact in the pharmaceutical industry. Technological advancement and the rising application of plastic bottles in solid and even liquid oral medicines have added to market growth for pharmaceutical plastic bottles. However, the rise in the price of plastics due to fluctuating prices of crude oil and various regulations would reflect on the increase in the price of plastics, which may affect the consumption of the product and further hinder the growth of the market studied.
  • Plastic bottles are increasingly used for aseptic filling and packaging in the industry. Market vendors provide aseptic bottle filling and packaging services in various regions. For instance, LSNE offers aseptic dropper bottle filling services. The company has an automated filling line capable of filling standard multi-dose three-piece bottles in 5 ml and 10 ml bottles and sterile multi-dose bottles.
  • Asia-Pacific has a prominent base for the production of PET resin and polymers, which is also aiding the growth of the market with no issues of a supply shortage of raw material. China is one of the largest producing and consuming countries of PET bottles.
  • With the increasing demand for medicine and other essential goods at an all-time high, a lack of available packaging to package and ship them further caused a significant interruption in supply chains. However, the demand increased for some medicines used in patients with COVID-19. These included some anesthetics, antibiotics, muscle relaxants, and some off-label medicines. This led to the supply of plastic bottles in the pharmaceutical companies.

Pharmaceutical Plastic Bottles Market Trends

HDPE Segment to Report the Highest Growth Rate

  • HDPE is used to manufacture various types of bottles, and among those, un-pigmented bottles are translucent, with excellent stiffness and barrier properties. The material has a pigmented variety, which can package light-sensitive drugs in the pharmaceutical industry. These materials are suited for packaging products with a short shelf life. According to American Chemical Council, in 2021, the United States produced 123.9 billion pounds of resins, in which thermoplastics accounted for roughly 86% of total production. High-density polyethylene (HDPE) was the most produced resin that year, with an output of 22 billion pounds.
  • HDPE also has excellent chemical resistance, which presents it as a valuable material for packaging various chemicals and medicinal products. Pigmented HDPE bottles are witnessed to have improved stress crack resistance than un-pigmented HDPE material. The blow-molding application of HDPE makes it more durable and more versatile than PP and LDPE materials. It also has excellent resistance to most solvents and high tensile strength compared to other forms of polyethylene materials.
  • HDPE is also primarily used for larger containers in the commercial sector as it has a high strength-to-weight ratio in common polymers and is less brittle than PP. It maintains a lightweight nature in molding, making it suitable for larger containers, like plastic canisters.
  • Further, there have been various research and development activities by multiple players in the market. For instance, in April 2021, Advil maker GSK Consumer Healthcare (GSK) announced a commitment to reducing the plastic in more than 80 million Advil bottles by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By 2022, Advil is expected to reduce plastic in nearly all bottles available in stores and online, except the brand's Easy Open bottles. The new barrier resin technology reduces the amount of resin required to mold and craft the high-density polyethylene (HDPE) bottles while maintaining barrier protection properties.

North America Accounts for a Significant Market Share

  • The US plastic bottles market is estimated to grow at a steady rate, owing to the constantly increasing consumption and industrial applications of plastic-made containers and bottles. According to the Plastics Industry Association (PLASTICS), the market demand for plastic bottles continues to expand in the United States.
  • According to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans would spend USD 635 to USD 655 billion on pharmaceuticals. As a result, the United States will be the country with the greatest pharmaceutical spending.
  • Moreover, according to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans will spend USD 635 to USD 655 billion on pharmaceuticals. As a result, it will almost certainly be the country with the most significant pharmaceutical spending.
  • The plastic resin and products sector employs 93,000 people across 1,932 establishments. With usage in almost every modern product, plastic products are in demand in Canada in most sectors of the economy, with three categories packaging, construction, and automotive accounting for 69% of plastic end use.

Pharmaceutical Plastic Bottles Industry Overview

The pharmaceutical plastic bottle market is fragmented with the presence of many players like Amcor Limited. Berry Plastics Group, Inc., Aptar Pharma, Gerresheimer AG, Graham Packaging Company, Alpha Packaging, and Alpack Plastic Packaging. The players have adopted various organic and inorganic strategies such as mergers & acquisitions, partnerships, new product launches, and collaborations to dominate the market.

  • December 2021 - Comar announced that it acquired Omega Packaging, an injection, and blow-molded product manufacturer. Omega Packaging's line of child-resistant (CR) closures and precision mold-building capabilities advance Comar's strategy to serve healthcare customers with end-to-end custom manufacturing capabilities and an expanded product portfolio.
  • September 2021 - Clearlake Capital Group portfolio company Pretium Packaging agreed to acquire US-based Alpha Packaging from Irving Place Capital for an undisclosed sum. Alpha Packaging and Pretium Packaging will allow the combined entity to offer a wide range of advanced packaging solutions to both firms' existing customer bases and new customers.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyer
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Growing Need for Lightweight Pharma Bottles by Consumers
    • 5.1.2 Increasing Spending on Healthcare and Pharmaceutical to Augment the Market Growth
  • 5.2 Market Restraints
    • 5.2.1 Increasing Raw Material Costs
    • 5.2.2 Environmental Concerns over Usage of Plastics

6 MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polyethylene Terephthalate (PET)
    • 6.1.2 Poly Propylene (PP)
    • 6.1.3 Low-density Poly Ethylene (LDPE)
    • 6.1.4 High-density Poly Ethylene (HDPE)
  • 6.2 By Type
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Other Types
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 Germany
      • 6.3.2.3 France
    • 6.3.3 Asia
      • 6.3.3.1 China
      • 6.3.3.2 India
      • 6.3.3.3 Japan
    • 6.3.4 Australia and New Zealand
    • 6.3.5 Latin America
      • 6.3.5.1 Brazil
      • 6.3.5.2 Argentina
      • 6.3.5.3 Mexico
    • 6.3.6 Middle East and Africa
      • 6.3.6.1 Saudi Arabia
      • 6.3.6.2 United Arab Emirates
      • 6.3.6.3 South Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Amcor Limited
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Berry Group Inc.
    • 7.1.4 Aptar Pharma
    • 7.1.5 O.Berk Company LLC
    • 7.1.6 Alpha Packaging
    • 7.1.7 Pro-Pac Packaging Ltd
    • 7.1.8 COMAR LLC
    • 7.1.9 Gil Plastic Products Ltd
    • 7.1.10 Drug Plastics Group
    • 7.1.11 Frapak Packaging

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS